NEXGEL, Inc. (NXGL) Key Metrics
NXGL valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $2.7M
- Enterprise value
- $9.5M
- P/E (TTM)
- —
- Forward P/E
- 1.4
- PEG ratio
- —
- Price / sales
- 0.2
- Price / book
- 0.5
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.81
NXGL key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsNXGL returns How much profit the business earns on the capital it uses.
NXGL financial health Debt, liquidity and how easily interest is covered.
NXGL efficiency & capital use Working capital cycle and where the cash goes.
NXGL returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NXGL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NXGL key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Share price at fiscal year-end | $32.20 | $89.20 | $42.60 | $25.00 | $52.20 | — | — | — | — | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −58.7% | −62.8% | −51.2% | −48.1% | −70.9% | — | −581.8% | −416.8% | −134.3% | −223.7% |
| Return on invested capital (ROIC) | −37.8% | −48.5% | −69.5% | −86.6% | −94.1% | −151.8% | −230.8% | −329.3% | −107.9% | −185.5% |
| Return on assets (ROA) | −28.0% | −31.3% | −31.1% | −34.7% | −44.8% | −109.2% | −146.3% | −231.2% | −88.4% | −140.8% |
| Return on tangible assets | −34.7% | −36.3% | −37.1% | −47.3% | −25.9% | −119.2% | −101.7% | −255.5% | −106.6% | −140.8% |
| Free cash flow margin | −12.1% | −49.6% | −96.2% | −150.8% | −194.8% | −313.5% | −253.0% | −69.8% | −39.4% | −61.2% |
| Financial health | ||||||||||
| Total debt | $3.1M | $2.8M | $2.8M | $2.1M | $4.3M | $1.3M | $917,000 | — | — | — |
| Cash & short-term investments | $317,000 | $1.8M | $2.7M | $6.6M | $13.3M | $32,000 | $261,000 | $1 | — | — |
| Net debt | $2.8M | $1.0M | $98,000 | −$4.5M | −$9.1M | $1.2M | $656,000 | −$1 | — | — |
| Debt / equity | 0.69 | 0.49 | 0.60 | 0.27 | 0.35 | 17.99 | 2.41 | — | — | — |
| Debt / assets | 0.30 | 0.26 | 0.28 | 0.20 | 0.25 | 0.57 | 0.49 | — | — | — |
| Current ratio | 1.47 | 2.07 | 1.98 | 8.74 | 4.82 | 0.27 | 0.64 | 0.89 | 0.95 | 0.67 |
| Quick ratio | 0.75 | 1.36 | 1.46 | 8.15 | 4.72 | 0.10 | 0.50 | 0.64 | 0.50 | 0.26 |
| Interest coverage | -98.6 | -43.9 | -231.8 | -2.5 | -1.3 | -226.0 | — | — | — | — |
| Working capital | $1.4M | $2.6M | $2.5M | $6.6M | $11.0M | −$969,000 | −$287,000 | −$46,000 | −$11,000 | −$127,000 |
| Invested capital | $7.2M | $6.8M | $4.8M | $3.1M | $3.0M | $1.3M | $1.0M | $280,999 | $625,000 | $794,000 |
| Tangible asset value | $3.1M | $4.1M | $3.7M | $7.3M | $11.7M | −$287,000 | $380,000 | $281,000 | $625,000 | $794,000 |
| Net current asset value | −$1.2M | $211,000 | $263,000 | $4.8M | $9.0M | −$1.8M | −$997,000 | −$97,000 | −$70,000 | −$210,000 |
| Capital allocation | ||||||||||
| Capex / revenue | 0.6% | 5.1% | 17.0% | 4.7% | 17.3% | 46.3% | 43.5% | 14.1% | 0.4% | 0.0% |
| Capex / depreciation | 0.09 | 0.92 | 1.57 | 0.32 | 2.38 | 6.24 | 4.66 | 0.97 | 0.02 | 0.00 |
| Stock-based compensation / revenue | 5.7% | 4.2% | 5.3% | 14.6% | 18.4% | 34.4% | 0.6% | 9.3% | 0.4% | 0.6% |
| R&D / revenue | 0.0% | 0.9% | 2.5% | 17.9% | 2.0% | — | — | — | — | — |
| SG&A / revenue | 68.8% | 68.0% | 83.1% | 137.5% | 155.1% | 292.1% | 249.2% | 108.5% | — | — |
| Efficiency | ||||||||||
| Days sales outstanding | 25.7 | 32.9 | 38.2 | 38.4 | 33.2 | 47.4 | 34.6 | 11.0 | 15.8 | 12.6 |
| Days of inventory on hand | 102.0 | 94.3 | 89.5 | 80.8 | 62.0 | 65.4 | 45.7 | 20.8 | 24.8 | 25.5 |
| Days payables outstanding | 68.1 | 77.6 | 73.6 | 52.9 | 107.9 | 220.9 | 142.5 | 23.6 | 20.8 | 23.7 |
| Cash conversion cycle (days) | 59.5 | 49.6 | 54.0 | 66.3 | -12.7 | -108.1 | -62.2 | 8.2 | 19.9 | 14.3 |
| Receivables turnover | 14.22 | 11.10 | 9.56 | 9.50 | 11.00 | 7.70 | 10.54 | 33.28 | 23.03 | 29.08 |
| Payables turnover | 5.36 | 4.70 | 4.96 | 6.91 | 3.38 | 1.65 | 2.56 | 15.45 | 17.57 | 15.41 |
| Inventory turnover | 3.58 | 3.87 | 4.08 | 4.52 | 5.89 | 5.58 | 7.98 | 17.52 | 14.70 | 14.34 |
| Asset turnover | 1.07 | 0.83 | 0.40 | 0.15 | 0.16 | 0.33 | 0.55 | 2.71 | 1.85 | 1.71 |
| Average receivables | $803,000 | $783,000 | $427,500 | $215,500 | $141,000 | $87,500 | $68,000 | $66,500 | $86,500 | $74,000 |
| Average payables | $1.3M | $1.3M | $749,000 | $259,500 | $456,000 | $584,000 | $333,500 | $110,000 | $105,000 | $147,000 |
| Average inventory | $1.9M | $1.5M | $910,500 | $396,500 | $262,000 | $173,000 | $107,000 | $97,000 | $125,500 | $158,000 |
| Intangibles / total assets | 17.3% | 17.6% | 14.6% | 3.2% | 2.0% | 15.9% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from NXGL's annual financial statements (latest annual report filed March 31, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
NXGL valuation and financial ratios
NEXGEL earned a return on equity of −58.7% and a return on invested capital of −37.8% in fiscal 2025. It ended the year with $3.1 million of debt and $0.3 million in cash and short-term investments, net debt of $2.8 million.
See the NXGL income statement, the NXGL chart for price history, or the NXGL stock overview for the latest quote and news.
NXGL key metrics FAQ
What is NEXGEL's return on equity?
NEXGEL's return on equity (ROE) was −58.7% in fiscal 2025: net income of -$3.0 million on average shareholders' equity of $5.1 million.
What is NEXGEL's ROIC?
NEXGEL's return on invested capital was −37.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does NEXGEL have?
NEXGEL had total debt of $3.1 million at the end of fiscal 2025, a debt-to-equity ratio of 0.69.
What is NEXGEL's current ratio?
NEXGEL's current ratio was 1.47 at the end of fiscal 2025: current assets were 1.47 times current liabilities.